. 2022 Aug 10;2022(8):CD015207. doi: 10.1002/14651858.CD015207

NCT02021435.

Study name	Tibet salt reduction study
Methods	Design: Cluster‐randomised trial Country: Tibet Setting: Villages from Damxung and Maizhokunggar county
Participants	Inclusion criteria: All family households (including children and adults) in selected villages Exclusion criteria (families): any family member reporting the use of a potassium‐sparing diuretic or potassium supplement; has serious renal impairment or life expectancy < 6 months
Interventions	Intervention: Salt substitute provided to households free of charge. To receive health education on salt reduction Comparator: Buy own normal salt. To receive health education on salt reduction
Outcomes	Primary: Blood pressure Secondary: Total mortality, cardiovascular mortality, life expectancy, serum cholesterol and random blood glucose levels (> 60 years)
Starting date	April 2014
Contact information	Contact person(s): Xingshan Zhao Email: [email protected]
Notes	Sponsors and Collaborators: Beijing Jishuitan Hospital; the George Institute for Global Health at PUHSC; the George Institute for Global Health, Australia; Science and Technology Department of Ningxia; People's Hospital of Tibet; People's Hospital of Maizhokunggar; Tibet University; Peking University; People's Hospital of Damxung County, Tibet